Biliary Tract Cancer clinical trials at UCSD
2 research studies open to eligible people
My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
open to eligible people ages 18 years and up
This multicenter, non-randomized, open-label study will evaluate the efficacy and safety of six treatment regimens in participants with advanced solid tumors for whom therapies that will convey clinical benefit are not available and/or are not suitable options per the treating physician's judgment.
La Jolla, California and other locations
Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers
open to eligible people ages 1 month and up
This is a Phase 1/2, multi-center, open-label study designed to evaluate the safety and efficacy of LOXO-195 when administered orally to patients age ≥ 1 month and older with NTRK fusion cancers treated with a prior TRK inhibitor.
La Jolla, California and other locations
Last updated: